Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future? World J Methodol. 2023 Sep 20;13(4):194-209. doi: 10.5662/wjm.v13.i4.194.
Antonietta Gerarda Gravina 1, Raffaele Pellegrino 2, Tommaso Durante 3, Giovanna Palladino 2, Rossella D'Onofrio 2, Simone Mammone 2, Giusi Arboretto 2, Salvatore Auletta 2, Giuseppe Imperio 2, Andrea Ventura 2, Mario Romeo 2, Alessandro Federico 2 |
Author information 1Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples 80138, Italy. antoniettagerarda.gravina@unicampania.it. 2Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples 80138, Italy. 3Mental Health Department, "S. Pio" Hospital, Benevento 82100, Italy. Abstract Inflammatory bowel disease (IBD) is a chronic digestive disease that requires continuous monitoring by healthcare professionals to determine the appropriate therapy and monitor short-term and long-term complications. The progressive development of information technology has enabled healthcare personnel to deliver care services to patients remotely. Therefore, various applications of telemedicine in IBD management have evolved, including telemonitoring, teleconsulting, teleducation, telenursing, telenutrition, and telepathology. While evidence has been provided for some telemedicine applications, targeted studies are still required. This review summarises the major studies that have evaluated telemedicine and its application in the management of IBD. |
© Copyright 2013-2024 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only.
Use of this website is governed by the GIHF terms of use and privacy statement.